Business ❯Finance ❯Pharmaceuticals

Drug Development

Novo Nordisk GLP-1 Agonists Roche Weight-Loss Pill Pfizer Eli Lilly GLP-1 Treatments Bristol Myers Squibb Weight Loss Medications

Bristol Myers Squibb Raises 2025 Forecast After Surpassing Q1 Expectations

The pharmaceutical giant reports $11.2 billion in revenue, driven by strong growth-drug sales, while addressing tariff risks and cost-cutting plans.

Pfizer Exceeds Q4 Earnings Expectations with Strong Covid Product Sales and Cost Cuts